PTX3 and nutritional deficiency disease: Data further upholds the usefulness of standardizing a high-sensitivity method for PTX3 measurement as a wide-ranging clinical biomarker, with potential to assess inflammatory status, malnutrition, CVD, and renal fibrosis and to predict all-cause mortality in dialysis patients with a greater accuracy than the conventional inflammatory biomarkers.